Teladoc Health (NYSE:TDOC) Stock Price Down 6.4% – Here’s Why

22 Jul 2026, 13:01 by Teresa Graham · The Cerbat Gem

Teladoc Health, Inc. (NYSE:TDOC – Get Free Report) was down 6.4% during trading on Wednesday . The stock traded as low as $9.22 and last traded at $9.0860. Approximately 452,760 shares traded hands during trading, a decline of 92% from the average session volume of 5,373,788 shares. The stock had previously closed at $9.71.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on TDOC. Barclays cut their target price on shares of Teladoc Health from $8.50 to $7.00 and set an “equal weight” rating for the company in a research report on Thursday, March 26th. Canaccord Genuity Group increased their price target on shares of Teladoc Health from $10.00 to $11.00 and gave the stock a “buy” rating in a research report on Tuesday. Bank of America lifted their price target on shares of Teladoc Health from $9.00 to $10.50 and gave the stock a “buy” rating in a research note on Tuesday, July 7th. Weiss Ratings raised shares of Teladoc Health from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Friday, May 22nd. Finally, Citigroup upped their price objective on Teladoc Health from $6.00 to $7.00 and gave the stock a “neutral” rating in a research note on Tuesday, May 5th. Five analysts have rated the stock with a Buy rating, eleven have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat, Teladoc Health currently has a consensus rating of “Hold” and a consensus target price of $7.73.

View Our Latest Report on Teladoc Health

Teladoc Health Stock Performance

The company has a current ratio of 2.80, a quick ratio of 2.72 and a debt-to-equity ratio of 0.75. The company has a market cap of $1.63 billion, a P/E ratio of -9.28 and a beta of 2.10. The business’s 50 day simple moving average is $7.92 and its 200 day simple moving average is $6.48.

Teladoc Health (NYSE:TDOC – Get Free Report) last posted its quarterly earnings results on Wednesday, April 29th. The health services provider reported ($0.36) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.35) by ($0.01). The firm had revenue of $613.85 million during the quarter, compared to the consensus estimate of $611.04 million. Teladoc Health had a negative return on equity of 11.45% and a negative net margin of 6.81%.The business’s revenue for the quarter was down 2.5% compared to the same quarter last year. During the same quarter in the previous year, the company earned ($0.53) earnings per share. Teladoc Health has set its FY 2026 guidance at -1.050–0.750 EPS and its Q2 2026 guidance at -0.300–0.200 EPS. Sell-side analysts predict that Teladoc Health, Inc. will post -0.92 earnings per share for the current fiscal year.

Insider Activity

In other Teladoc Health news, insider Adam C. Vandervoort sold 7,906 shares of the stock in a transaction on Tuesday, June 2nd. The stock was sold at an average price of $7.63, for a total value of $60,322.78. Following the completion of the sale, the insider owned 110,261 shares in the company, valued at approximately $841,291.43. This represents a 6.69% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider Carlos Nueno sold 6,196 shares of the firm’s stock in a transaction dated Tuesday, June 2nd. The shares were sold at an average price of $7.63, for a total value of $47,275.48. Following the sale, the insider directly owned 57,671 shares in the company, valued at approximately $440,029.73. This represents a 9.70% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last 90 days, insiders sold 39,195 shares of company stock worth $299,058. 0.70% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in the business. Jupiter Asset Management Ltd. boosted its stake in Teladoc Health by 293.9% in the 4th quarter. Jupiter Asset Management Ltd. now owns 3,860,076 shares of the health services provider’s stock worth $27,021,000 after purchasing an additional 2,880,008 shares during the period. Quantinno Capital Management LP boosted its position in shares of Teladoc Health by 128.0% during the first quarter. Quantinno Capital Management LP now owns 2,621,378 shares of the health services provider’s stock worth $14,287,000 after acquiring an additional 1,471,631 shares during the last quarter. Pale Fire Capital SE grew its stake in Teladoc Health by 74.8% during the first quarter. Pale Fire Capital SE now owns 3,398,491 shares of the health services provider’s stock valued at $18,522,000 after acquiring an additional 1,454,288 shares in the last quarter. Dimensional Fund Advisors LP increased its holdings in Teladoc Health by 23.8% in the 3rd quarter. Dimensional Fund Advisors LP now owns 6,889,194 shares of the health services provider’s stock valued at $53,260,000 after acquiring an additional 1,325,106 shares during the last quarter. Finally, Trexquant Investment LP purchased a new stake in Teladoc Health in the 4th quarter worth $9,156,000. 76.82% of the stock is owned by hedge funds and other institutional investors.

About Teladoc Health

(Get Free Report)

Teladoc Health, Inc is a leading global provider of virtual healthcare services, offering on-demand medical consultations via phone, video, and mobile app platforms. The company connects patients with licensed physicians and specialists for non-emergency medical issues, mental health support, dermatology, and chronic condition management. By leveraging digital technologies and data analytics, Teladoc aims to enhance accessibility, reduce healthcare costs, and improve patient outcomes through personalized care plans and remote monitoring.